| Metric | შპს ფარმაცევტული სახლი + | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾61.6m₾65.5m | ₾2.11bn₾1.93bn |
| Revenue growth | -5.8% | 9.5% |
| Profitability | ||
| EBITDA | -₾11.7m-₾2.7m | — |
| EBITDA margin | -18.9%-4.1% | — |
| Net profit | -₾11.2m-₾3.1m | ₾1.12bn₾1.02bn |
| Net margin | -18.2%-4.8% | 53.0%53.1% |
| Balance sheet | ||
| Total assets | ₾66.5m₾48.9m | ₾31.77bn₾28.33bn |
| Total equity | -₾17.3m-₾6.0m | ₾4.75bn₾4.27bn |
| ROE | — | 23.6%24.0% |